PHADE

PHADE

Cardiology A clinical trial–Pneumatic HeartMate® Assist as Destination Evaluation
Mentioned in ?
References in periodicals archive ?
The study, called PHADE (Pneumatic HeartMate Assist as Destination Evaluation), will examine the safety, quality of life, and cost of permanent implantation of the HeartMate IP using the HeartPak portable driver in 50 national and international patients who are not transplant candidates in the US.
The study called PHADE (Pneumatic HeartMate Assist as Destination Evaluation) is underway at The Heart Institute of Spokane under the direction of Dr.
Such devices as those under evaluation in the PHADE study could have, in the future, a tremendous impact on the survival statistics for congestive heart failure," says Icenogle.
The study, called PHADE, (Pneumatic HeartMate Assist as Destination Evaluation), will examine the safety, quality of life, and cost of permanent implantation of the HeartMate IP using the HeartPak portable driver in 50 national and international patients who are not transplant candidates in the USA.
This experience was the impetus to approach the FDA seeking the PHADE study approval.